Biognosys
Biognosys believe that the decoding of the proteome will impact the life sciences more than the genome revolution a decade ago, and they strive to be the company that enables the routine analysis of proteomes in each research and clinical laboratory worldwide.Biognosys offers a unique next-generation solution for precise quantification of large proteomes in biological samples. Their technology provides unprecedented depth and quality of protein expression data for more effective biomarker and drug-target discovery and validation. Biognosys is a spin-off from the leading proteomics lab of Prof. Ruedi Aebersold, ETH Zurich.
Tech Stack (31 technologies)
Frequently Asked Questions
What technologies does Biognosys use?+
Biognosys uses 31 technologies including Bootstrap, cdnjs, Google Analytics.
What industry is Biognosys in?+
Biognosys operates in the Biotechnology industry.
Where is Biognosys based?+
Biognosys is headquartered in Switzerland.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026